← Back to Clinical Trials
Recruiting NCT05781100

NCT05781100 Investigating Baby Behavior and Family Technology Use Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05781100
Status Recruiting
Phase
Sponsor California Polytechnic State University-San Luis Obispo
Condition Mobile Phone Use
Study Type INTERVENTIONAL
Enrollment 345 participants
Start Date 2023-01-16
Primary Completion 2027-01-01

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Technology Use during Feeding Conditions

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 345 participants in total. It began in 2023-01-16 with a primary completion date of 2027-01-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Maternal sensitivity and contingent responsiveness to infant behavioral cues is an important contributor to infants' developing capacities to self-regulate. During early infancy, feeding interactions comprise a significant portion of mother-infant dyadic interactions and high-quality feeding interactions provide both nutritive and socioemotional benefits; recent data suggest that, for many dyads, mothers' sensitive responsiveness during feeding interactions is routinely impacted by the omnipresence of portable technology. The objective of the proposed research is to better understand the development and possible impacts of maternal technology use on infant feeding interactions, emotion and intake regulation, and sociobehavioral and growth outcomes.

Eligibility Criteria

Eligibility Criteria At the time of recruitment, eligibility criteria for participants will include: * 18 years of age or older * In 3rd trimester of singleton pregnancy * History of healthy, low-risk pregnancy * Lives within 50 miles of the Cal Poly campus * Owns a mobile device After the child is born, eligibility criteria for participants will remain in the study will include: * Infant was born term (gestational age ≥37 weeks) Exclusion criteria include * Mother has an untreated medical or psychiatric condition (e.g. bipolar disorder) that could impede study participation or affect mother-infant interaction * Mother is participating in another interventional study that influences parenting, mother-infant interactions, feeding practices, or technology use * The mother is unwilling or unable to commit to longitudinal follow-ups of herself or her child * Infant was born preterm (gestational age \<37 weeks) * Infant diagnosed with fetal abnormality or medical condition that interferes with oral feeding (e.g., feeding disorder, milk protein allergy) or development * Infant diagnosed with developmental delay (e.g., Down's syndrome)

Contact & Investigator

Central Contact

Alison K Ventura, PhD

✉ akventur@calpoly.edu

📞 (805) 756-5693

Frequently Asked Questions

Who can join the NCT05781100 clinical trial?

This trial is open to participants of all sexes, studying Mobile Phone Use. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05781100 currently recruiting?

Yes, NCT05781100 is actively recruiting participants. Contact the research team at akventur@calpoly.edu for enrollment information.

Where is the NCT05781100 trial being conducted?

This trial is being conducted at San Luis Obispo, United States.

Who is sponsoring the NCT05781100 clinical trial?

NCT05781100 is sponsored by California Polytechnic State University-San Luis Obispo. The trial plans to enroll 345 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology